Bumetanide Tablet Shortage

Last Updated: May 2, 2025
Status: Discontinued

To Be Discontinued:

• Bumetanide, Tablet, .5 mg (Upsher-Smith Laboratories, LLC)
• Bumetanide, Tablet, 1 mg (Upsher-Smith Laboratories, LLC)
• Bumetanide, Tablet, 2 mg (Upsher-Smith Laboratories, LLC)

Bumetanide, Tablet, .5 mg (Upsher-Smith Laboratories, LLC)

NDC Code: 0832-0540-11
Status: To Be Discontinued
Date of update: May 2, 2025
Update type: New
Therapeutic category: Cardiovascular
Date discontinued: May 2, 2025
Initial posting date: May 2, 2025
Contact info: 800-654-2299

Bumetanide, Tablet, 1 mg (Upsher-Smith Laboratories, LLC)

NDC Code: 0832-0541-10
Status: To Be Discontinued
Date of update: May 2, 2025
Update type: New
Therapeutic category: Cardiovascular
Date discontinued: May 2, 2025
Initial posting date: May 2, 2025
Contact info: 800-654-2299

Bumetanide, Tablet, 1 mg (Upsher-Smith Laboratories, LLC)

NDC Code: 0832-0541-11
Status: To Be Discontinued
Date of update: May 2, 2025
Update type: New
Therapeutic category: Cardiovascular
Date discontinued: May 2, 2025
Initial posting date: May 2, 2025
Contact info: 800-654-2299

Bumetanide, Tablet, 2 mg (Upsher-Smith Laboratories, LLC)

NDC Code: 0832-0542-10
Status: To Be Discontinued
Date of update: May 2, 2025
Update type: New
Therapeutic category: Cardiovascular
Date discontinued: May 2, 2025
Initial posting date: May 2, 2025
Contact info: 800-654-2299

Bumetanide, Tablet, 2 mg (Upsher-Smith Laboratories, LLC)

NDC Code: 0832-0542-11
Status: To Be Discontinued
Date of update: May 2, 2025
Update type: New
Therapeutic category: Cardiovascular
Date discontinued: May 2, 2025
Initial posting date: May 2, 2025
Contact info: 800-654-2299

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer